Canlyniadau Chwilio - Carol Feghali‐Bostwick

Mireinio'r Canlyniadau
  1. 1
    The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis

    The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis gan Joe E. Mouawad, Carol Feghali‐Bostwick

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    The Pro-Fibrotic Factor IGFBP-5 Induces Lung Fibroblast and Mononuclear Cell Migration

    The Pro-Fibrotic Factor IGFBP-5 Induces Lung Fibroblast and Mononuclear Cell Migration gan Hidekata Yasuoka, Yukie Yamaguchi, Carol Feghali‐Bostwick

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The Mighty Fibroblast and Its Utility in Scleroderma Research

    The Mighty Fibroblast and Its Utility in Scleroderma Research gan Sara M. Garrett, DeAnna Baker Frost, Carol Feghali‐Bostwick

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis

    Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis gan Patrizia Fuschiotti, Adriana T. Larregina, Johnan Ho, Carol Feghali‐Bostwick, Thomas A. Medsger

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca2+-dependent and regulated by KCa3.1 K+ channels

    Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca2+-dependent and regulated by KCa3.1 K+ channels gan Katy M. Roach, Carol Feghali‐Bostwick, Heike Wulff, Yassine Amrani, Peter Bradding

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis

    Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis gan William R. Coward, Keira Watts, Carol Feghali‐Bostwick, Gisli Jenkins, Linhua Pang

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent

    Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent gan Katy M. Roach, Heike Wulff, Carol Feghali‐Bostwick, Yassine Amrani, Peter Bradding

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators

    IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators gan Xinh-Xinh Nguyen, Lutfiyya N. Muhammad, Paul J. Nietert, Carol Feghali‐Bostwick

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase‐2 in idiopathic pulmonary fibrosis

    A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase‐2 in idiopathic pulmonary fibrosis gan William R. Coward, Carol Feghali‐Bostwick, Gisli Jenkins, Alan J. Knox, Linhua Pang

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis

    Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis gan William R. Coward, Keiria Watts, Carol Feghali‐Bostwick, Alan J. Knox, Linhua Pang

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes

    Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes gan Christine Peoples, Thomas A. Medsger, Mary Lucas, Bedda L. Rosario, Carol Feghali‐Bostwick

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis

    Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis gan Ludivine Renaud, Willian A. da Silveira, Naoko Takamura, Gary Hardiman, Carol Feghali‐Bostwick

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition

    Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition gan Joseph M. Pilewski, Lixin Liu, Adam C. Henry, Alycia V. Knauer, Carol Feghali‐Bostwick

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy

    Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy gan Swati Bhattacharyya, Minghua Wu, Feng Fang, Warren G. Tourtellotte, Carol Feghali‐Bostwick, John Varga

    Cyhoeddwyd 2011
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    A Peptide Derived from Endostatin Ameliorates Organ Fibrosis

    A Peptide Derived from Endostatin Ameliorates Organ Fibrosis gan Yukie Yamaguchi, Takahisa Takihara, Roger Chambers, Kristen L. Veraldi, Adriana T. Larregina, Carol Feghali‐Bostwick

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis

    Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis gan Meredith L. Sosulski, Rafael Góngora, Carol Feghali‐Bostwick, Joseph A. Lasky, Cecilia G. Sánchez

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions

    Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions gan Sara M. Garrett, Eileen Hsu, Justin M. Thomas, Joseph M. Pilewski, Carol Feghali‐Bostwick

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct?

    Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct? gan Erica L. Herzog, Aditi Mathur, Andrew M. Tager, Carol Feghali‐Bostwick, Frank Schneider, John Varga

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Localized expression of tenascin in systemic sclerosis–associated pulmonary fibrosis and its regulation by insulin‐like growth factor binding protein 3

    Localized expression of tenascin in systemic sclerosis–associated pulmonary fibrosis and its regulation by insulin‐like growth factor binding protein 3 gan Monique L. Brissett, Kristen L. Veraldi, Joseph M. Pilewski, Thomas A. Medsger, Carol Feghali‐Bostwick

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis

    The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis gan Katy M. Roach, S. Mark Duffy, William R. Coward, Carol Feghali‐Bostwick, Heike Wulff, Peter Bradding

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: